• American Board of Internal Medicine
• American Board of Internal Med-Infectious Diseases

• Associate Chief of Staff, Medical Service, Miami VA Healthcare System
• Clinical Director
• Medical Director, UHealth Infection Control, Occupational Health, Workers Compensation
• Professor of Clinical Medicine

My principal research focus has been to better understand the epidemiology, pathogenesis, treatment and prevention of UTI in women. I was on the faculty of the University of Washington, Seattle, WA, for 22 years before moving to the University of Miami in 2006.  I see many women with recurrent UTI, many episodes of which are caused by highly antimicrobial-resistant uropathogens. I have collaborated with basic scientists in the Scott Hultgren group at Washington University in St. Louis, Missouri, for over 12 years to better understand and develop novel strategies for management of UTIs in women. In addition, I continue to collaborate in UTI research with my colleagues at the University of Washington, Seattle, WA. I also have a strong interest in antimicrobial stewardship and methods to reduce our dependence on antimicrobials in the treatment and prevention of infections, especially UTI. 

• Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 2013;369:1883-91.
• Abbo LM, Cosgrove SE, Pottinger PS, Pereyra M, Sinkowitz-Cochran R, Srinivasan A, Webb DJ, Hooton TM. Medical students' perceptions and knowledge about antimicrobial stewardship: how are we educating our future prescribers? Clin Infect Dis 2013;57:631-8.
• Hooton TM. Uncomplicated urinary tract infection. N Engl J Med 2012;366:1028-1037.
• Hooton TM, Roberts PL, Stapleton AE. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: A randomized trial. JAMA 2012:307:583-589.
• Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103–e120 (Executive summary: Clin Infect Dis 2011;52:561-564).

I have a 30-year history of clinical care and research in Infectious Diseases and especially UTI in women since 1981 when I started my fellowship in infectious diseases at the University of Washington.  My principal research focus has been to better understand the epidemiology, pathogenesis, treatment and prevention of UTI in women. I was on the faculty of the University of Washington, Seattle, WA, for 22 years before moving to the University of Miami in 2006.  I see many women with recurrent UTI, many episodes of which are caused by highly antimicrobial-resistant uropathogens. I have collaborated with basic scientists in the Scott Hultgren group at Washington University in St. Louis, Missouri, for over 13 years to better understand and develop novel strategies for management of UTIs in women. In addition, I continue to collaborate in UTI research with my colleagues at the University of Washington, Seattle, WA. I also have a strong interest in antimicrobial stewardship and methods to reduce our dependence on antimicrobials in the treatment and prevention of infections, especially UTI. I have authored or co-authored  over 140 peer-reviewed journal articles and over 200 other articles, book chapters and abstracts in the fields of UTI, antimicrobial stewardship, STDs, and HIV/AIDS.

• Download Thomas M. Hooton, M.D.'s CV